WO2011003240A1 - Formulation comprising terpolymer and active substance, and preparation thereof - Google Patents

Formulation comprising terpolymer and active substance, and preparation thereof Download PDF

Info

Publication number
WO2011003240A1
WO2011003240A1 PCT/CN2009/072723 CN2009072723W WO2011003240A1 WO 2011003240 A1 WO2011003240 A1 WO 2011003240A1 CN 2009072723 W CN2009072723 W CN 2009072723W WO 2011003240 A1 WO2011003240 A1 WO 2011003240A1
Authority
WO
WIPO (PCT)
Prior art keywords
active substance
formulation
terpolymer
formulation according
monomer
Prior art date
Application number
PCT/CN2009/072723
Other languages
French (fr)
Inventor
Qi Wu
Weidong He
Jing Dreher
Uwe Kardorff
Guangzhao Zhang
Original Assignee
Basf (China) Company Limited
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf (China) Company Limited, Basf Se filed Critical Basf (China) Company Limited
Priority to PCT/CN2009/072723 priority Critical patent/WO2011003240A1/en
Priority to PCT/EP2010/059767 priority patent/WO2011003961A2/en
Publication of WO2011003240A1 publication Critical patent/WO2011003240A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04Acids; Metal salts or ammonium salts thereof
    • C08F220/06Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/16Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C08F220/1818C13or longer chain (meth)acrylate, e.g. stearyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen

Definitions

  • the present invention relates to a type of formulations comprising a terpolymer and an active substance, preparation thereof, and the use thereof in the preparation of ready-for-use formulations.
  • active substances are ideally used as aqueous formulations (mainly as aqueous solutions or aqueous dispersions) in various fields.
  • active substances such as insecticides, acaricides, nematicides, fungicides and herbicides as well as growth regulators are frequently formulated and sold as concentrates, such as aqueous concentrates or as concentrates in organic solvent, for example suspensions or emulsions, and also as solid concentrates, such as powders, dusts or granules.
  • concentrates such as aqueous concentrates or as concentrates in organic solvent, for example suspensions or emulsions, and also as solid concentrates, such as powders, dusts or granules.
  • pharmaceutically and cosmetically active substances and food additives as well as active substances used in biological field, such as vitamins, provitamins, proteins, RNA and DNA and the like, are also generally formulated into formulations in aqueous medium for transportation and/or usage.
  • active substances used in biological field such as vitamins, provitamins, proteins, RNA and DNA and the like.
  • the main problems are that, many active substances have low solubility, i.e., generally less than 10 g/1 at 23°C/1 atm. (1013 mbar).
  • these active substances When these active substances are formulated into aqueous formulations or aqueous ready-for-use formulations, they form unstable heterogeneous systems in which the active substance is present as emulsified or dispersed phase in a continuous aqueous phase.
  • the active substances tend to separate out of the system, for example by crystallization or creaming or sedimentation. This reduces the availability of the active substance, resulting in low utilization of the active substance.
  • WO2008/040786 disclosed a comb-copolymer, and the use of the comb-copolymer in stabilizing the aqueous phase that contains an insoluble or slightly soluble active substance, to obtain a stable aqueous formulation.
  • the comb-copolymer is used as dispersant for dispersing and stabilizing the active substances that have been divided into small size, in water.
  • the present invention solved the problems in the prior art by synthesizing a terpolymer and preparing a formulation based on the visco-elastic behavior of the macromolecule.
  • the inventive terpolymer there is a strong interaction between the inventive terpolymer and the active substance, thus for a given amount of formulation of the present invention, the loading level of the active substance can be substantively increased.
  • the introduction of hydrophilic component in the terpolymer can shorten the interaction time among dispersed microparticles. More importantly, the introduction of hydrophobic component and a proper chain extension, not only the formation of the dispersed microparticles is induced and promoted, but also the relaxation time of the chains inside each microparticle is prolonged.
  • the dispersion state of the formulations can be adjusted when the formulation is diluted with substantive amount of water.
  • the relaxation time of the chains inside the dispersed phase can be made much longer than the interaction time between the dispersed phases. In other words, within the relatively shorter interaction time, the dispersed phase is in glassy state which prevents aggregation, and thus enables the formation of a stable formulation system.
  • the formulations can be prepared with simple procedures and easy to apply.
  • the invention relates to a formulation comprising terpolymer and active substance (D), said terpolymer comprises main chain segment (A), hydrophobic pendent chains (B), and hydrophilic pendent chains (C).
  • the formulation according to the invention is described as comprises core-shell particles formed by the terpolymer and the active substances (D), wherein the hydrophilic pendent chains (C) forms said shell, the hydrophobic pendent chains (B) forms said core, and said main chain segment (A) of the terpolymer combines with said active substance (D), and said active substance (D) is encapsulated between said core and said shell.
  • the invention is not to be limited by this description.
  • the said core-shell structure is only provided for the convenience of describing and understanding the invention, not for limiting the invention in any way.
  • Structure of the inventive terpolymer comprises main chain segment (A), hydrophobic pendent chains (B) and hydrophilic pendent chains (C).
  • the main chain segment (A) can be either hydrophobic or hydrophilic, depending on the condition.
  • the molecular weight of the inventive terpolymer is at least 100,000 g/mol, preferably at least 150,000 g/mol, more preferably at least 200,000 g/mol, and at most 4,000,000 g/mol, preferably at most 3,000,000 g/mol, more preferably at most 2,000,000 g/mol, most preferably at most 1,000,000 g/mol. In a preferred embodiment of the invention, the molecular weight of the inventive terpolymer is l,300,000g/mol.
  • the main chain segment (A) interacts with the active substance (D) to weaken the aggregation tendency of the active substance (D), in particular the tendency of separating, crystallizing, flocculating or precipitating out of the system, so as to enables the formation of stable formulations.
  • an environment sensitive component is used as the main chain segment (A), i.e., the main chain segment (A) will change its property (such as being hydrophilic or hydrophobic) under different conditions (such as changing in temperature and pH value).
  • the main chain segment (A) of the terpolymer which is formed with monomer (a) is hydrophobic under low pH conditions and may combine with the active substance (D), while being hydrophilic at high pH conditions and may release the active substance (D).
  • This property of main chain segment (A) will help encapsulating said active substance (D) in the stable formulations under certain conditions, while releasing the active substance from the stable formulation under other conditions.
  • said main chain segment (A) is derived from monomer (a)
  • said hydrophobic pendent chain (B) is derived from monomer (b)
  • said hydrophilic pendent chain (C) is derived from monomer (c).
  • monomers (a), (b) and (c) are copolymerized to form the inventive terpolymer.
  • the functional groups contained in monomer (a) will constitute the main chain segment (A) which in turn will complex with the active substance (D), while monomers (b) and (c) copolymerized into the main chain segment (A), and the groups contained in monomers (b) and (c) form the pendent chain (B) and (C) respectively.
  • pendent chains (B) and (C) are attached to the main chain segment (A) during the formation of the main chain segment (A).
  • Monomer (a) that contributes to the formation of the main chain segment (A) can be a member selected from the group consisting of (meth)acrylic acids, vinyl benzene sulfonic acid, vinyl pyridine, and N-isopropyl acrylamide, and the like.
  • Monomer (b) that contributes to the formation of the hydrophobic pendent chain (B) can be for example a hydrophobic vinyl monomer, such as alkyl (meth)acrylate, styrene and/or vinyl acetate.
  • alkyl (meth)acrylate When alkyl (meth)acrylate is used as monomer (b), the number of the carbon atom in the alkyl group is at least 8, preferably at least 10, more preferably at least 12, and at most 30, preferably at most 24, more preferably at most 20, and most preferably 18.
  • Monomer (c) that contributes to the formation of the hydrophobic pendent chain (C) can be a member selected from the group consisting of for example (polyethylene glycol monomethylether) acrylate (i.e., PEG acrylate), acrylamide, vinylpyrrolidone, and N,N-dimethylacrylamide.
  • the molecular weight of the PEG is at least 500g/mol, preferably at least lOOOg/mol, and up to 8000g/mol, preferably up to lOOOOg/mol.
  • the term "terpolymer” according to the invention does not exclude the presence of a small amount of other structures such as other hydrophobic pendent chains other than the hydrophobic pendent chain (B).
  • said other hydrophobic pendent chains is the ones that are derived from di(meth)acrylates.
  • the terpolymer of the present invention can be illustrated as following.
  • hydrophobic pendent chain (B) and the hydrophobic pendent chain (C) constitute the chain of the terpolymer together with the main chain segment (A).
  • the ratios between main chain segment (A), the hydrophobic pendent chain (B) and the hydrophilic pendent chain (C) influence the formation of hydrophobic core structure and hydrophilic shell structure as well as the loading of active substance (D) in said core-shell structure.
  • the amount of the main chain segment (A) is 17-60% by weight
  • the amount of the hydrophobic pendent chain (B) is 20-56% by weight
  • the amount of the hydrophilic pendent chain (C) is 20-40% by weight, all based on the total weight of the terpolymer.
  • a di(meth)acrylate can be further added as a comonomer, such as ethylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, or polyethylene glycol di(meth)acrylate.
  • the structural unit of monomer (b) is randomly distributed along the main chain of the terpolymer.
  • each of the structural unit has a hydrocarbon type pendent chain of preferably more than 12 carbon atoms, more preferably each of the structural unit has a hydrocarbon type pendent chain of 12 -24 carbon atoms, more preferably 18 carbon atoms.
  • Active substances in the sense of the present invention are defined as substances that can manifest a particular activity or function or reactive under particular circumstance.
  • the terms "active substance” and “effect substance” are used interchangeably and are synonymous in the context of this patent application.
  • suitable active substance include small molecule active substance such as insecticides, acaricides, nematicides, fungicides and herbicides and growth regulators, and high molecular weight active substance such as proteins, RNA and DNA.
  • the inventive terpolymer can also be used to disperse and stabilize functional inorganic compounds, such as quantum-dots, as well as magnetic, light-emitting and catalytic substances, into polymeric core-shell particles.
  • slightly soluble means a solubility of the active substance in water of less than 10 g/1, usually of less than 5 g/1 and in particular of less than 1 g/1 and especially of less than 0.1 g/1, at 25 0 C and 1 atm (1013 mbar).
  • the interaction between the main chain segment (A) and the active substance (D) is strong that hinders the aggregation tendency of the active substance (D).
  • Examples of such interaction include hydrogen bond, charge interaction, hydrophobicity interaction, etc.
  • the particle with core-shell structure formed according to the invention has the particle size and particle size distribution of from hundreds nanometers to tens of microns, more frequently from hundreds nanometers to several microns.
  • Loading of active substance (D) in the formulation according to the invention can be up to about 350% by weight based on the polymer used, and up to about 200mg/ml based on the solvent used.
  • Another aspect of the present invention relates to a process for the preparation of the inventive formulation.
  • said process include the steps of:
  • the appearance of the obtained formulation can be clear and transparent, or can be a milky colloid.
  • reaction type involved in above process is not critical to the implementation of the present invention. They can be any of commonly known reaction type, such as radical polymerization.
  • reaction temperature can be determined by those skilled in the art.
  • the lower limit of the reaction temperature used in polymerization is O 0 C, preferably 2O 0 C, more preferable 3O 0 C, while the upper limit is 100 0 C, preferably 8O 0 C, more preferably 7O 0 C, particular preferably 6O 0 C.
  • Solvent used in the process of the present invention is important for the implementation of the present invention.
  • Said solvent must be able to dissolve all the reactant involved in the reactions and active substance (D), and essentially inert to the reactions.
  • Said solvent preferably comprises ester of lower aliphatic carboxylic acid with lower aliphatic alcohol, such as ethyl acetate and butyl acetate.
  • pH vale of inventive formulation is preferably from about 1 to about 5.
  • Molar ratio of monomer (a) : monomer (b) : monomer (c) : active substance (D) in step a2) can be determined by a skilled person through experiments.
  • stably dispersed inventive formulation could be obtained directly.
  • the formulation can be readily used after dilution 50-100 times with water.
  • the present invention also relates to a process for the preparation of a ready-for-use formulation comprising the inventive formulation, said process including the step of mixing the inventive formulation with water, preferably 50-100 times of water.
  • Epoxiconazole (EP), PEG acrylate, methacrylic acid (MAA), octodecyl acrylate (ODA) and azo-bis-isobutyronitrile (AIBN) were added into ethyl acetate (30 mL) according to the concentration as shown in Table 1 respectively, and homogenized with agitation. After that, a small amount of ethylene dimethacrylate (EDMA) was added to the polymerization mixture and the copolymerization was performed at 60 0 C under nitrogen atmosphere for 24 h. The procedure was repeated five times with the changing of the amount of epoxiconazole (EP) to obtain five test samples 1-5 of the formulation. Table 1 shows the visual appearance of the formulation after polymerization.
  • EDMA ethylene dimethacrylate
  • a formulation with 66.7 g/1 epoxiconazole is obtainable from the polymerization of methacrylic acid (8.3 g/1), octodecyl acrylate (16.7 g/1), PEG acrylate (8.3 g/1) and a small amount of ethylene dimethacrylate (0.5 g/ml) in ethyl acetate.
  • the formulation is a emulation and has no precipitate over 2 hours. After latex particles separated out, the system was in a homogeneous state with slight stirring.
  • **A formulation with 166.7 g/1 epoxiconazole is obtainable from the polymerization of methacrylic acid (26.7 g/1), octodecyl acrylate (16.7 g/1), PEG acrylate (8.3 g/1) and a small amount of ethylene dimethacrylate (0.6 g/ml) in ethyl acetate.
  • the formulation has no aggregrative particle.
  • Epoxiconazole (EP), PEG acrylate, methacrylic acid (MAA), octodecyl acrylate (ODA) and azo-bis-isobutyronitrile (AIBN) were added into ethyl acetate (20 ml) according to the concentration as shown in Table 2, and homogenized with agitation. The reaction was performed at 60 0 C under nitrogen atmosphere for 24 h. The procedure was repeated five times with the changing of the amount of MAA to obtain five test samples 1-5 of the formulation. Table 2 shows the visual appearance of the formulation after polymerization.
  • Sample A, sample B and sample C are obtained from Test 6, Test 9 and Test 8 in Table 2, respectively.
  • Sample A-I, sample B-I and sample C-I are the mixture prepared by the re-dispersion of sample A, sample B and sample C in water, respectively.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)

Abstract

A formulation comprising a terpolymer and an active substance and the producing process thereof are disclosed. Said terpolymer comprises 17-60 wt.% of the main chain segment, 20-56 wt.% of the hydrophobic pendent chains, and 20-40 wt.% hydrophilic pendent chains, based on the total weight of the terpolymer. The main chain segment is formed from the monomer which is selected from (meth)acrylic acid, vinyl benzene sulfonic acid or N-isopropyl acrylamide. The hydrophobic pendent chain is derived from hydrophobic vinyl, such as alkyl (meth)acrylate, styrene and/or vinyl acetate. The hydrophilic pendent chain is derived from monomer which is selected from (polyethylene glycol monomethylether) acrylate, acrylamide, vinylpyrrolidone, or N,N-dimethylacrylamide.

Description

Formulations Comprising Terpolymer and Active Substance, Preparation and
Use Thereof
Field of the invention
The present invention relates to a type of formulations comprising a terpolymer and an active substance, preparation thereof, and the use thereof in the preparation of ready-for-use formulations.
Background of the invention
Many types of active substances are ideally used as aqueous formulations (mainly as aqueous solutions or aqueous dispersions) in various fields. For example, in the field of plant protection, active substances such as insecticides, acaricides, nematicides, fungicides and herbicides as well as growth regulators are frequently formulated and sold as concentrates, such as aqueous concentrates or as concentrates in organic solvent, for example suspensions or emulsions, and also as solid concentrates, such as powders, dusts or granules. These formulations, before their application, are generally diluted to the desired application concentration by addition of a large amount of water. Also, pharmaceutically and cosmetically active substances and food additives, as well as active substances used in biological field, such as vitamins, provitamins, proteins, RNA and DNA and the like, are also generally formulated into formulations in aqueous medium for transportation and/or usage. Thus, it is necessary for the active substances to be effectively stable or dissolved in aqueous.
However, the main problems are that, many active substances have low solubility, i.e., generally less than 10 g/1 at 23°C/1 atm. (1013 mbar). When these active substances are formulated into aqueous formulations or aqueous ready-for-use formulations, they form unstable heterogeneous systems in which the active substance is present as emulsified or dispersed phase in a continuous aqueous phase. The active substances tend to separate out of the system, for example by crystallization or creaming or sedimentation. This reduces the availability of the active substance, resulting in low utilization of the active substance. Moreover, for purpose of proper metering of the active substance, it is also desirable to have a stable system in which the active substance is homogeneously distributed.
To solve these problems, conventional methods, such as lyophilization, utilization of various surfactant and/or emulsifier and/or dispersant, have been generally used to stably distribute the active substance in aqueous formulation or aqueous ready-for-use formulations, in order to obtain a stable system and to avoid formation of large aggregate or droplet of active substance, and to enhance the utilization of the active substance. However, such conventional measures are typically unsatisfactory. The separation of the active substance, for example creaming or sedimentation of the active substance, may still occur, in particular if the aqueous formulation is stored for a relatively long time at elevated temperature and/or at highly variable temperatures or in the vicinity of the freezing point. This problem is particularly significant if the active substance has a tendency to crystallize.
WO2008/040786 disclosed a comb-copolymer, and the use of the comb-copolymer in stabilizing the aqueous phase that contains an insoluble or slightly soluble active substance, to obtain a stable aqueous formulation. The comb-copolymer is used as dispersant for dispersing and stabilizing the active substances that have been divided into small size, in water.
However, in the prior art, when polymer is used to prepare stable aqueous formulations of water insoluble or slightly soluble active substances, generally, said polymer is synthesized first, then such polymer is mixed with an active substance under certain conditions. In a formulation formed from the polymer and water insoluble or slightly soluble active substances, generally the interaction between the active substances and the polymer is weak, such that it is difficult for the active substances to be dispersed into the polymer matrix, in particular in the case of high level of loading of the active substances. Thus, in order to obtain the stability of the final formulation, the loading level of water insoluble or slightly soluble active substance in the formulation is significantly limited. The amount of active substance in given amount of stable formulation is very low. In addition, as the polymer has to be formed first, then mixed with active substance, the preparation process of the formulation according to the prior art is complicated, and is economically undesirable.
Surprisingly, the present invention solved the problems in the prior art by synthesizing a terpolymer and preparing a formulation based on the visco-elastic behavior of the macromolecule. In the formulations of the invention, there is a strong interaction between the inventive terpolymer and the active substance, thus for a given amount of formulation of the present invention, the loading level of the active substance can be substantively increased. The introduction of hydrophilic component in the terpolymer can shorten the interaction time among dispersed microparticles. More importantly, the introduction of hydrophobic component and a proper chain extension, not only the formation of the dispersed microparticles is induced and promoted, but also the relaxation time of the chains inside each microparticle is prolonged. With the change of the preparation conditions, different formulation forms such as emulsion or suspension are obtained, and the dispersion state of the formulations can be adjusted when the formulation is diluted with substantive amount of water. With these measures, the relaxation time of the chains inside the dispersed phase can be made much longer than the interaction time between the dispersed phases. In other words, within the relatively shorter interaction time, the dispersed phase is in glassy state which prevents aggregation, and thus enables the formation of a stable formulation system. The formulations can be prepared with simple procedures and easy to apply.
Detailed description of the invention
Formulation
In one aspect, the invention relates to a formulation comprising terpolymer and active substance (D), said terpolymer comprises main chain segment (A), hydrophobic pendent chains (B), and hydrophilic pendent chains (C).
For purpose of facilitating better understanding of the present invention, the formulation according to the invention is described as comprises core-shell particles formed by the terpolymer and the active substances (D), wherein the hydrophilic pendent chains (C) forms said shell, the hydrophobic pendent chains (B) forms said core, and said main chain segment (A) of the terpolymer combines with said active substance (D), and said active substance (D) is encapsulated between said core and said shell. However, the invention is not to be limited by this description. In other words, the said core-shell structure is only provided for the convenience of describing and understanding the invention, not for limiting the invention in any way.
Terpolymer
Structure of the inventive terpolymer comprises main chain segment (A), hydrophobic pendent chains (B) and hydrophilic pendent chains (C). The main chain segment (A) can be either hydrophobic or hydrophilic, depending on the condition. The molecular weight of the inventive terpolymer is at least 100,000 g/mol, preferably at least 150,000 g/mol, more preferably at least 200,000 g/mol, and at most 4,000,000 g/mol, preferably at most 3,000,000 g/mol, more preferably at most 2,000,000 g/mol, most preferably at most 1,000,000 g/mol. In a preferred embodiment of the invention, the molecular weight of the inventive terpolymer is l,300,000g/mol.
In the present invention, the main chain segment (A) interacts with the active substance (D) to weaken the aggregation tendency of the active substance (D), in particular the tendency of separating, crystallizing, flocculating or precipitating out of the system, so as to enables the formation of stable formulations.
In the present invention, preferably an environment sensitive component is used as the main chain segment (A), i.e., the main chain segment (A) will change its property (such as being hydrophilic or hydrophobic) under different conditions (such as changing in temperature and pH value). For example, the main chain segment (A) of the terpolymer which is formed with monomer (a) is hydrophobic under low pH conditions and may combine with the active substance (D), while being hydrophilic at high pH conditions and may release the active substance (D). This property of main chain segment (A) will help encapsulating said active substance (D) in the stable formulations under certain conditions, while releasing the active substance from the stable formulation under other conditions.
In general, said main chain segment (A) is derived from monomer (a), said hydrophobic pendent chain (B) is derived from monomer (b), and said hydrophilic pendent chain (C) is derived from monomer (c).
In a preferred embodiment of the present invention, monomers (a), (b) and (c) are copolymerized to form the inventive terpolymer. After the polymerization, the functional groups contained in monomer (a) will constitute the main chain segment (A) which in turn will complex with the active substance (D), while monomers (b) and (c) copolymerized into the main chain segment (A), and the groups contained in monomers (b) and (c) form the pendent chain (B) and (C) respectively. In this embodiment, pendent chains (B) and (C) are attached to the main chain segment (A) during the formation of the main chain segment (A).
Monomer (a) that contributes to the formation of the main chain segment (A) can be a member selected from the group consisting of (meth)acrylic acids, vinyl benzene sulfonic acid, vinyl pyridine, and N-isopropyl acrylamide, and the like. Monomer (b) that contributes to the formation of the hydrophobic pendent chain (B) can be for example a hydrophobic vinyl monomer, such as alkyl (meth)acrylate, styrene and/or vinyl acetate. When alkyl (meth)acrylate is used as monomer (b), the number of the carbon atom in the alkyl group is at least 8, preferably at least 10, more preferably at least 12, and at most 30, preferably at most 24, more preferably at most 20, and most preferably 18. Monomer (c) that contributes to the formation of the hydrophobic pendent chain (C) can be a member selected from the group consisting of for example (polyethylene glycol monomethylether) acrylate (i.e., PEG acrylate), acrylamide, vinylpyrrolidone, and N,N-dimethylacrylamide. When (polyethylene glycol monomethylether) acrylate (i.e., PEG acrylate) is used as Monomer (c), the molecular weight of the PEG is at least 500g/mol, preferably at least lOOOg/mol, and up to 8000g/mol, preferably up to lOOOOg/mol. The term "terpolymer" according to the invention does not exclude the presence of a small amount of other structures such as other hydrophobic pendent chains other than the hydrophobic pendent chain (B). One example of said other hydrophobic pendent chains is the ones that are derived from di(meth)acrylates.
With acrylic acid, C18 acrylate and PEG acrylate being used as monomers (a), (b) and (c), respectively, the terpolymer of the present invention can be illustrated as following.
Figure imgf000006_0001
(a) (b) (c)
Monomers (a) ^ (b) and (c)
Figure imgf000006_0002
terpolymer
In a further preferred embodiment, the hydrophobic pendent chain (B) and the hydrophobic pendent chain (C) constitute the chain of the terpolymer together with the main chain segment (A).
In the inventive terpolymer, the ratios between main chain segment (A), the hydrophobic pendent chain (B) and the hydrophilic pendent chain (C) influence the formation of hydrophobic core structure and hydrophilic shell structure as well as the loading of active substance (D) in said core-shell structure. Preferably in the inventive terpolymer, the amount of the main chain segment (A) is 17-60% by weight, the amount of the hydrophobic pendent chain (B) is 20-56% by weight, and the amount of the hydrophilic pendent chain (C) is 20-40% by weight, all based on the total weight of the terpolymer. Furthermore, based on the total weight of the terpolymer, less than 1.5% by weight of a di(meth)acrylate can be further added as a comonomer, such as ethylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, or polyethylene glycol di(meth)acrylate.
The structural unit of monomer (b) is randomly distributed along the main chain of the terpolymer. In case the Monomer (b) is an alkyl (meth)acrylate, each of the structural unit has a hydrocarbon type pendent chain of preferably more than 12 carbon atoms, more preferably each of the structural unit has a hydrocarbon type pendent chain of 12 -24 carbon atoms, more preferably 18 carbon atoms.
Active substance (D)
Active substances in the sense of the present invention are defined as substances that can manifest a particular activity or function or reactive under particular circumstance. The terms "active substance" and "effect substance" are used interchangeably and are synonymous in the context of this patent application. Examples of suitable active substance include small molecule active substance such as insecticides, acaricides, nematicides, fungicides and herbicides and growth regulators, and high molecular weight active substance such as proteins, RNA and DNA. Moreover, the inventive terpolymer can also be used to disperse and stabilize functional inorganic compounds, such as quantum-dots, as well as magnetic, light-emitting and catalytic substances, into polymeric core-shell particles.
For the purpose of the present invention, slightly soluble means a solubility of the active substance in water of less than 10 g/1, usually of less than 5 g/1 and in particular of less than 1 g/1 and especially of less than 0.1 g/1, at 250C and 1 atm (1013 mbar).
Manner of Incorporation
In the present invention, the interaction between the main chain segment (A) and the active substance (D) is strong that hinders the aggregation tendency of the active substance (D). Examples of such interaction include hydrogen bond, charge interaction, hydrophobicity interaction, etc.
The particle with core-shell structure formed according to the invention has the particle size and particle size distribution of from hundreds nanometers to tens of microns, more frequently from hundreds nanometers to several microns.
Loading of active substance (D) in the formulation according to the invention can be up to about 350% by weight based on the polymer used, and up to about 200mg/ml based on the solvent used. Preparation process of the formulation
Another aspect of the present invention relates to a process for the preparation of the inventive formulation. In a preferred embodiment of the present invention, said process include the steps of:
al) Dissolving monomers (a), (b) and (c) and active substance (D) in a solvent,
a2) In-situ copolymerization of monomers (a), (b) and (c) into the terpolymer in the presence of the solvent and the active substance (D), producing the inventive formulation comprising the terpolymer and the active substance (D).
The appearance of the obtained formulation can be clear and transparent, or can be a milky colloid.
The reaction type involved in above process is not critical to the implementation of the present invention. They can be any of commonly known reaction type, such as radical polymerization.
Various known initiators can be used in the polymerization, such as azo initiator, peroxide initiator and redox initiating system. Reaction temperature can be determined by those skilled in the art. In a preferred embodiment, the lower limit of the reaction temperature used in polymerization is O0C, preferably 2O0C, more preferable 3O0C, while the upper limit is 1000C, preferably 8O0C, more preferably 7O0C, particular preferably 6O0C.
Solvent used in the process of the present invention is important for the implementation of the present invention. Said solvent must be able to dissolve all the reactant involved in the reactions and active substance (D), and essentially inert to the reactions. Said solvent preferably comprises ester of lower aliphatic carboxylic acid with lower aliphatic alcohol, such as ethyl acetate and butyl acetate.
pH vale of inventive formulation is preferably from about 1 to about 5.
Molar ratio of monomer (a) : monomer (b) : monomer (c) : active substance (D) in step a2) can be determined by a skilled person through experiments.
With the process of the present invention, stably dispersed inventive formulation could be obtained directly. For example, the formulation can be readily used after dilution 50-100 times with water.
Readv-for-use formulation comprising the inventive formulation
The present invention also relates to a process for the preparation of a ready-for-use formulation comprising the inventive formulation, said process including the step of mixing the inventive formulation with water, preferably 50-100 times of water.
In a preferred embodiment of the present invention, during the formation of the ready-for-use formulation, with the changing of the conditions (for example changing of pH value by way of water dilution), property of main chain segment (A) changes, thus achieving the goal of releasing the active substance (D).
Examples
The present invention is further illustrated by the following examples. These examples are for illustrative purpose only and can not be used to limit the scope of the present invention.
1. Preparation of the formulation of the present invention
Example 1
Epoxiconazole (EP), PEG acrylate, methacrylic acid (MAA), octodecyl acrylate (ODA) and azo-bis-isobutyronitrile (AIBN) were added into ethyl acetate (30 mL) according to the concentration as shown in Table 1 respectively, and homogenized with agitation. After that, a small amount of ethylene dimethacrylate (EDMA) was added to the polymerization mixture and the copolymerization was performed at 600C under nitrogen atmosphere for 24 h. The procedure was repeated five times with the changing of the amount of epoxiconazole (EP) to obtain five test samples 1-5 of the formulation. Table 1 shows the visual appearance of the formulation after polymerization.
Table 1 Dispersion copolymerization of MAA, ODA, PEG acrylate and EDMA (CEDMA = 0.6 mg/niL) in the presence of different amounts of epoxiconazole (CEP)
Figure imgf000009_0001
* A formulation with 66.7 g/1 epoxiconazole is obtainable from the polymerization of methacrylic acid (8.3 g/1), octodecyl acrylate (16.7 g/1), PEG acrylate (8.3 g/1) and a small amount of ethylene dimethacrylate (0.5 g/ml) in ethyl acetate. The formulation is a emulation and has no precipitate over 2 hours. After latex particles separated out, the system was in a homogeneous state with slight stirring.
**A formulation with 166.7 g/1 epoxiconazole is obtainable from the polymerization of methacrylic acid (26.7 g/1), octodecyl acrylate (16.7 g/1), PEG acrylate (8.3 g/1) and a small amount of ethylene dimethacrylate (0.6 g/ml) in ethyl acetate. The formulation has no aggregrative particle.
Example 2
Epoxiconazole (EP), PEG acrylate, methacrylic acid (MAA), octodecyl acrylate (ODA) and azo-bis-isobutyronitrile (AIBN) were added into ethyl acetate (20 ml) according to the concentration as shown in Table 2, and homogenized with agitation. The reaction was performed at 60 0C under nitrogen atmosphere for 24 h. The procedure was repeated five times with the changing of the amount of MAA to obtain five test samples 1-5 of the formulation. Table 2 shows the visual appearance of the formulation after polymerization.
Table 2. Dispersion copolymerization of MAA, PEG acrylate and ODA
Figure imgf000010_0001
2. Reparation of ready-for-use formulation of the present invention
Under magnetic stirring, the samples listed in Table 2 were added dropwise into distillated water at the volume ratio of the sample to water of 1:100. Sample A, sample B and sample C is obtained from Test 6, Test 9 and Test 8 in Table 2, respectively. Sample A-I, sample B-I and sample C-I are the mixture prepared by the re-dispersion of sample A, sample B and sample C in water, respectively.
Appearance of each thinned re-dispersion is shown in figure 1.

Claims

Claims:
1. A formulation comprising a terpolymer and an active substance (D), characterized in that said terpolymer comprises main chain segment (A), hydrophobic pendent chains (B), and hydrophilic pendent chains (C).
2. The formulation according to claim 1, characterized in that the main chain segment (A) is hydrophilic or hydrophobic under different environmental conditions.
3. The formulation according to claims 1 or 2, characterized in that the main chain segment (A) is formed from monomer (a) which is selected from the group consisting of (meth)acrylic acid, vinyl benzene sulfonic acid and N-isopropyl acrylamide.
4. The formulation according to claims 1 or 2, characterized in that the hydrophobic pendent chain (B) is derived from monomer (b) which is a hydrophobic vinyl monomer.
5. The formulation according to claim 4, characterized in that the monomer (b) is selected from alkyl (meth)acrylate, styrene and/or vinyl acetate.
6. The formulation according to claim 1 or 2, characterized in that the hydrophilic pendent chain (C) is derived from monomer (c) which is selected from the group consisting of (polyethylene glycol monomethylether) acrylate, acrylamide, vinylpyrrolidone, and N,N-dimethylacrylamide.
7. The formulation according to claim 1 or 2, characterized in that, in the terpolymer, the amount of the main chain segment (A) is 17-60% by weight, the amount of the hydrophobic pendent chain (B) is 20-56% by weight, and the amount of the hydrophilic pendent chain (C) is 20-40% by weight, all based on the total weight of the terpolymer.
8. The formulation according to claim 1 or 2, characterized in that the structural unit of monomer (b) forming the hydrophobic pendent chain (B) is randomly distributed along the main chain of the terpolymer, and each of the structural unit has hydrocarbon type pendent chain of more than 12 carbon atoms, preferably each of the structural unit has a hydrocarbon type pendent chain of 12 -18 carbon atoms.
9. The formulation according to claim 1 or 2, characterized in that the active substance (D) comprises small molecule active substance, high molecular weight active substance, or functional inorganic compounds.
10. The formulation according to claim 9, characterized in that the small molecule active substance is selected from the group consisting of insecticides, fungicides, and herbicides; the high molecular weight active substance is selected from the group consisting of proteins, RNA and DNA; and the functional inorganic compounds is selected from the group consisting of quantum-dots, magnetic substance, light-emitting substance and catalytic substances.
11. A process for the preparation of the formulation according any one of claims 1-10, characterized in that the process include the steps of:
al) dissolving monomers (a), (b) and (c) and active substance (D) in the solvent,
a2) in-situ copolymerization of monomers (a), (b) and (c) into a terpolymer in the presence of the solvent and the active substance (D), producing the formulation comprising terpolymer and the active substance (D).
12. The process according to claim 11, characterized in that an initiator is used in the polymerization, preferably the initiator is selected from the group consisting of azo initiator, peroxide initiator and redox initiating system.
13. The process according to any one of claims 11-12, characterized in that reaction temperature used in polymerization is in the range between O0C-IOO0C, preferable 20°C-80°C, more preferable 30°C-70°C, particularly 3O0C- 6O0C.
14. The process according to any one of claims 11-13, characterized in that the solvent is selected from the group consisting of esters of lower aliphatic carboxylic acid with lower aliphatic alcohol, preferably ethyl acetate and butyl acetate.
15. A ready-for-use formulation comprising the formulation according to any one of claims 1-10.
16. A process for the preparation of the ready-for-use formulation according to claim 15, including the step of mixing the formulation of the present invention with water, preferably 50-100 times of water.
PCT/CN2009/072723 2009-07-10 2009-07-10 Formulation comprising terpolymer and active substance, and preparation thereof WO2011003240A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2009/072723 WO2011003240A1 (en) 2009-07-10 2009-07-10 Formulation comprising terpolymer and active substance, and preparation thereof
PCT/EP2010/059767 WO2011003961A2 (en) 2009-07-10 2010-07-08 Formulations comprising terpolymer and active substance, preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2009/072723 WO2011003240A1 (en) 2009-07-10 2009-07-10 Formulation comprising terpolymer and active substance, and preparation thereof

Publications (1)

Publication Number Publication Date
WO2011003240A1 true WO2011003240A1 (en) 2011-01-13

Family

ID=43428739

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/CN2009/072723 WO2011003240A1 (en) 2009-07-10 2009-07-10 Formulation comprising terpolymer and active substance, and preparation thereof
PCT/EP2010/059767 WO2011003961A2 (en) 2009-07-10 2010-07-08 Formulations comprising terpolymer and active substance, preparation and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/059767 WO2011003961A2 (en) 2009-07-10 2010-07-08 Formulations comprising terpolymer and active substance, preparation and use thereof

Country Status (1)

Country Link
WO (2) WO2011003240A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013149856A1 (en) * 2012-04-04 2013-10-10 Basf Se Agroformulation comprising copolymer of an amide, polyalkylene glycol (meth)acrylate, and alkyl (meth)acrylate
WO2013149925A1 (en) * 2012-04-04 2013-10-10 Basf Se Agroformulation comprising copolymer of vinyllactam, n-alkyl acrylamide, and alkyl (meth)acrylate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487738B2 (en) 2013-10-09 2016-11-08 Ecolab Usa Inc. Solidification matrix comprising a carboxylic acid terpolymer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018102A1 (en) * 2000-01-27 2003-01-23 Weston Rachel Clare Particulate compositions and their maufacture
CN1760227A (en) * 2005-07-07 2006-04-19 复旦大学 Nano granules possessing hydrophobic core and hydrophilic surface, preparation method and application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683132A (en) * 1982-04-30 1987-07-28 Minnesota Mining And Manufacturing Company Compositions, devices, and methods for extended control of insect activity
DK171065B1 (en) * 1988-08-24 1996-05-13 Allied Colloids Ltd Liquid enzyme-containing composition and process for preparing the same
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition
WO2001037660A1 (en) * 1999-11-19 2001-05-31 Nof Corporation Sustained-release preparation of aqueous dispersion type and process for producing the same
US20020134012A1 (en) * 2001-03-21 2002-09-26 Monsanto Technology, L.L.C. Method of controlling the release of agricultural active ingredients from treated plant seeds
DE502005002359D1 (en) * 2004-08-04 2008-02-07 Basf Ag PROCESS FOR PREPARING AQUEOUS ACTIVE COMPOSITIONS OF HARD SOLUBLE AGENTS IN WATER
CA2664242A1 (en) 2006-10-05 2008-04-10 Basf Se Comb polymers and use thereof for the production of active or effective ingredient formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018102A1 (en) * 2000-01-27 2003-01-23 Weston Rachel Clare Particulate compositions and their maufacture
CN1760227A (en) * 2005-07-07 2006-04-19 复旦大学 Nano granules possessing hydrophobic core and hydrophilic surface, preparation method and application

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013149856A1 (en) * 2012-04-04 2013-10-10 Basf Se Agroformulation comprising copolymer of an amide, polyalkylene glycol (meth)acrylate, and alkyl (meth)acrylate
WO2013149925A1 (en) * 2012-04-04 2013-10-10 Basf Se Agroformulation comprising copolymer of vinyllactam, n-alkyl acrylamide, and alkyl (meth)acrylate
CN104202975A (en) * 2012-04-04 2014-12-10 巴斯夫欧洲公司 Agroformulation comprising copolymer of an amide, polyalkylene glycol (meth)acrylate, and alkyl (meth)acrylate
CN104202978A (en) * 2012-04-04 2014-12-10 巴斯夫欧洲公司 Agroformulation comprising copolymer of vinyllactam, N-alkyl acrylamide, and alkyl (meth)acrylate
CN104202978B (en) * 2012-04-04 2016-06-22 巴斯夫欧洲公司 Comprise the agricultural mixture of the copolymer of vinyl lactam, N-alkyl acrylamide and (methyl) alkyl acrylate
CN104202975B (en) * 2012-04-04 2016-08-24 巴斯夫欧洲公司 Comprise the agricultural mixture of the copolymer of acid amides, PAG (methyl) acrylate and (methyl) alkyl acrylate
US9700048B2 (en) 2012-04-04 2017-07-11 Basf Se Agroformulation comprising copolymer of vinyllactam, N-alkyl acrylamide, and alkyl (meth)acrylate
EA032035B1 (en) * 2012-04-04 2019-03-29 Басф Се Pesticidal composition comprising copolymer of an amide, polyalkylene glycol (meth)acrylate and alkyl(meth)acrylate, process for preparing same, methods for controlling phytopathogenic fungi, unwanted plant growth and insect or mite infestation, method for regulating the growth of plants and seed treated with the composition

Also Published As

Publication number Publication date
WO2011003961A3 (en) 2011-08-25
WO2011003961A2 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
CN109988333B (en) Polystyrene microsphere
Zgheib et al. Cerium oxide encapsulation by emulsion polymerization using hydrophilic macroRAFT agents
CN101717479B (en) Amphiphilic gradient copolymer
EP2729002B1 (en) Micelle-coated organic crystalline particles
CN100563716C (en) Biocompatible monodisperse nano polymer carrier and preparation thereof and medicine-carrying method
EA013453B1 (en) Agrochemical dispersion
EP3150191A1 (en) Cosmetic composition containing amphiphilic anisotropic powder and method for preparing same
CN105131199B (en) A kind of preparation and preparation method and application
US20070224274A1 (en) Polymer Particles Containing Active Agents
BR102020005683A2 (en) PREPARATION OF A WATER DISPERSION OF VINYL ACETATE COPOLYMER PARTICLES AND A CYCLIC ACETAL CETENE MONOMER
CN103483601B (en) Preparation method for polymeric nanometer microsphere
CN105646891A (en) Amphiphilic ternary molecular brush polymer and vermicular mono-molecular micelle constructed by same
WO2011003240A1 (en) Formulation comprising terpolymer and active substance, and preparation thereof
EP3241542B1 (en) Co-emulsification composition containing various emulsification particle sizes and method for preparing same
CN103524966A (en) Aqueous polymer dispersons for stabilizing actives
CN103613697A (en) Preparation method of pH-sensitive polymer nano-latex
BR102020005610A2 (en) AQUEOUS DISPERSION OF VINYL ACETATE COPOLYMER PARTICLES AND A CYCLIC CETENE-ACETAL MONOMER
WO2020130994A2 (en) Polymodal and alkali soluble resin supported emulsion polymers
CN104987515B (en) A kind of method for preparing multiple emulsion using the step of parents' random copolymer self-assembled micelle one
Moustafa et al. Differential microemulsion polymerization as a new root for entrapment of drugs
WO2007071325A2 (en) Composition containing and active agent and polymeric carrier particles comprising a copolymer of a hydrophobic monomer and a hydrophilic polysaccharide
KR101027281B1 (en) Polyvinylalcohol particle for drug delivery system and preparation method thereof
JP5873714B2 (en) Method for producing sustained release particles
Dai et al. Preparation of poly (ethyleneglycol-co-acrylic acid) microspheres with divinylbenzne as crosslinker by distillation-precipitation polymerization
US20240041030A1 (en) Process for preparing microcapsules

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09846991

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09846991

Country of ref document: EP

Kind code of ref document: A1